Milestone Advisory Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,648
Closed -$233K 90
2021
Q4
$233K Hold
4,648
0.12% 82
2021
Q3
$247K Hold
4,648
0.15% 74
2021
Q2
$284K Hold
4,648
0.15% 70
2021
Q1
$227K Buy
+4,648
New +$218K 0.12% 74

Other funds holding LMAT

Milestone Advisory Partners's LMAT Position: Q1 2022 in Review

Milestone Advisory Partners sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 4,648 shares — an estimated $233K sold.

Milestone Advisory Partners first reported a position in LMAT in Q1 2021 and held it in 4 quarters. The position peaked at $284K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Milestone Advisory Partners reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
  • Milestone Advisory Partners sold 4,648 LeMaitre Vascular shares in Q1 2022, an estimated $233K.
  • Milestone Advisory Partners first reported a position in LeMaitre Vascular in Q1 2021 and held it in 4 quarters.
  • Milestone Advisory Partners's LeMaitre Vascular position peaked at $284K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Milestone Advisory Partners's 13F filing for Q1 2022, filed 10 May 2022.